Panthera Biopartners has experienced a resurgence in its oncology clinical trial division following its reopening earlier this year. The company has been selected by two large pharmaceutical companies to conduct oncology trials at its UK-based sites.   Panthera’s oncology division was previously forced to close due to its association with the Rutherford Specialist Cancer clinics, which underwent administration. However, the company has since expanded its existing clinical trial sites to ...